How PGIM India's Rs 112 crore Healthcare Fund picks CDMO stocks to generate alpha

PGIM India Healthcare Fund generated a 22% return over the past year by over-allocating to high-growth segments like CDMO, specialty pharma, and hospitals. Anandha Padmanabhan shares insights on navigating hospital capacity expansions, China-plus-one opportunities, GLP-1 dynamics, and key stock-selection strategies across healthcare sub-sectors.

This story was originally reported by Economic Times — Markets. As an automated real-time news aggregator, NewsToolBar provides multi-perspective indexing and AI summarization while directing full readership directly to primary publisher sources.